Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   A KSHV RNA-binding protein promotes FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation
  2. Majerciak,Vladimir; Alvarado-Hernandez, Beatriz; Ma, Yanping; Duduskar, Shivalee; Lobanov, Alexei; Cam, Maggie; Zheng,Zhi-Ming
  3. mBio. 2024, Dec 10; e0317224.
  1. 2.   Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages
  2. Menga, Alessio; Serra, Marina; Todisco, Simona; Riera-Domingo, Carla; Ammarah, Ummi; Ehling, Manuel; Palmieri,Erika; Di Noia, Maria Antonietta; Gissi, Rosanna; Favia, Maria; Pierri, Ciro L; Porporato, Paolo E; Castegna, Alessandra; Mazzone, Massimiliano
  3. EMBO molecular medicine. 2020, OCT 7; 12(10): e11210.
  1. 3.   Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model
  2. Higuchi, Takashi; Miyake, Kentaro; Sugisawa, Norihiko; Oshiro, Hiromichi; Zhang, Zhiying; Razmjooei, Sahar; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Singh, Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer letters. 2019, Jun 1; 451: 122-127.
  1. 4.   A Molecular Phylogeny of Living Primates
  2. Perelman, P.; Johnson, W. E.; Roos, C.; Seuanez, H. N.; Horvath, J. E.; Moreira, M. A. M.; Kessing, B.; Pontius, J.; Roelke, M.; Rumpler, Y.; Schneider, M. P. C.; Silva, A.; O'Brien, S. J.; Pecon-Slattery, J.
  3. Plos Genetics. 2011, Mar; 7(3): 17.
  1. 5.   A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
  2. Kelly, R. J.; Draper, D.; Chen, C. C.; Robey, R. W.; Figg, W. D.; Piekarz, R. L.; Chen, X. H.; Gardner, E. R.; Balis, F. M.; Venkatesan, A. M.; Steinberg, S. M.; Fojo, T.; Bates, S. E.
  3. Clinical Cancer Research. 2011, Feb; 17(3): 569-580.
  1. 6.   Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape
  2. Davis, R. M.; Matsumoto, S.; Bernardo, M.; Sowers, A.; Matsumoto, K. I.; Krishna, M. C.; Mitchell, J. B.
  3. Free Radical Biology and Medicine. 2011, Feb; 50(3): 459-468.
  1. 7.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 8.   Probing early growth response 1 interacting proteins at the active promoter in osteoblast cells using oligoprecipitation and mass spectrometry
  2. Meng, Z. J.; Camalier, C. E.; Lucas, D. A.; Veenstra, T. D.; Beck, G. R.; Conrads, T. P.
  3. Journal of Proteome Research. 2006, Aug; 5(8): 1931-1939.
  1. 9.   The Late Miocene radiation of modern Felidae: A genetic assessment
  2. Johnson, W. E.; Eizirik, E.; Pecon-Slattery, J.; Murphy, W. J.; Antunes, A.; Teeling, E.; O'Brien, S. J.
  3. Science. 2006, JAN 6; 311(5757): 73-77.
  1. 10.   A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors
  2. Rishi, V.; Potter, T.; Laudeman, J.; Reinhart, R.; Silvers, T.; Selby, M.; Stevenson, T.; Krosky, P.; Stephen, A. G.; Acharya, A.; Moll, J.; Oh, W. J.; Scudiero, D.; Shoemaker, R. H.; Vinson, C.
  3. Analytical Biochemistry. 2005, MAY 15; 340(2): 259-271.
  1. 11.   Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1
  2. Song, X.; Tao, Y. G.; Tan, Y. N.; Lee, L. M.; Deng, X. Y.; Wu, Q.; Cao, Y.
  3. Science in China Series C-Life Sciences. 2005, FEB; 48(1): 70-80.
  1. 12.   A molecular phylogeny for bats illuminates biogeography and the fossil record
  2. Teeling, E. C.; Springer, M. S.; Madsen, O.; Bates, P.; O'Brien, S. J.; Murphy, W. J.
  3. Science. 2005, JAN 28; 307(5709): 580-584.
  1. 13.   Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development
  2. Lee, S. Y.; Lee, F. S.; Moon, J. S.; Kim, J. I.; Park, J. B.; Lee, J. Y.; Park, M. J.; Kim, J.
  3. Experimental and Molecular Medicine. 2004, OCT 31; 36(5): 468-475.
  1. 14.   Concerted evolution and higher-order repeat structure of the 1.709 (satellite IV) family in bovids
  2. Modi, W. S.; Ivanov, S.; Gallagher, D. S.
  3. Journal of Molecular Evolution. 2004 58(4): 460-465.
  1. 15.   Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP- 1 transactivation
  2. Yang, H. S.; Knies, J. L.; Stark, C.; Colburn, N. H.
  3. Oncogene. 2003 22(24): 3712-3720.
  1. 16.   Placental mammal diversification and the Cretaceous-Tertiary boundary
  2. Springer, M. S.; Murphy, W. J.; Eizirik, E.; O'Brien, S. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(3): 1056-1061.
  1. 17.   A dominant negative c-jun specifically blocks okadaic acid- induced skin tumor promotion
  2. Thompson, E. J.; MacGowan, J.; Young, M. R.; Colburn, N.; Bowden, G. T.
  3. Cancer Research. 2002 62(11): 3044-3047.
  1. 18.   IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases
  2. Rajnavolgyi, E.; Benbernou, N.; Rethi, B.; Reynolds, D.; Young, H. A.; Magocsi, M.; Muegge, K.; Durum, S. K.
  3. Cellular Signalling. 2002 14(9): 761-769.
  1. 19.   Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently
  2. Young, M. R.; Nair, R.; Bucheimer, N.; Tulsian, P.; Brown, N.; Chapp, C.; Hsu, T. C.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2002 22(2): 587-598.
  1. 20.   Promoter function of the angiogenic inducer Cyr61 gene in transgenic mice: Tissue specificity, inducibility during wound healing, and role of the serum response element
  2. Latinkic, B. V.; Mo, F. E.; Greenspan, J. A.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Ross, S. R.; Lau, L. F.
  3. Endocrinology. 2001 142(6): 2549-2557.
  1. 21.   Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
  2. Young, M. R.; Li, J. J.; Rincon, M.; Flavell, R. A.; Sathyanarayana, B. K.; Hunziker, R.; Colburn, N.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(17): 9827-9832.
  1. 22.   Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
  2. Watts, R. G.; Huang, C. S.; Young, M. R.; Li, J. J.; Dong, Z. G.; Pennie, W. D.; Colburn, N. H.
  3. Oncogene. 1998 17(26): 3493-3498.
  1. 23.   Inhibition of AP-1 and NF-kappa B by manganese-containing superoxide dismutase in human breast cancer cells
  2. Li, J. J.; Oberley, L. W.; Fan, M.; Colburn, N. H.
  3. Faseb Journal. 1998 12(15): 1713-1723.
  1. 24.   Beta-Adrenergic Receptor-Induced Activation of Nerve Growth Factor Gene Transcription in Rat Cerebral Cortex Involves Ccaat/Enhancer-Binding Protein Delta
  2. Colangelo, A. M.; Johnson, P. F.; Mocchetti, I.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(18): 10920-10925.
  1. 25.   Maspin Gene Expression in Tumor Suppression Induced By Overexpressing Manganese-Containing Superoxide Dismutase Cdna in Human Breast Cancer Cells
  2. Li, J. J.; Colburn, N. H.; Oberley, L. W.
  3. Carcinogenesis. 1998 19(5): 833-839.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel